Canakinumab in Combination with Docetaxel Compared with Docetaxel Alone for the Treatment of Advanced Non-Small Cell Lung Cancer Following Platinum-Based Doublet Chemotherapy and Immunotherapy (CANOPY-2): A Multicenter, Randomized, Double-Blind, Phase 3 Trial
LUNG CANCER(2024)
关键词
Non-small cell lung cancer,Canakinumab,Docetaxel,Immunotherapy,ctDNA,CRP
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要